Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiao Lo

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Biomed Research International|December 11, 2013
CYP19 genetic polymorphism haplotype AASA is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancerSung-Hsin Kuo, Shi-Yi Yang, Huang-Chun Lien, et al.
Surgical Oncology|October 21, 2021
Factors predicting one or two sentinel lymph nodes to be accepted for sentinel lymph node biopsy alone after neoadjuvant therapy in initially node-positive breast cancer patientsLi-Wei Tsai, Yi-Hsuan Lee, Chiao Lo, et al.
Cancer Science|January 21, 2020
Using next-generation sequencing to redefine BRCAness in triple-negative breast cancerPo-Han Lin, Ming Chen, Li-Wei Tsai, et al.
World Journal of Surgical Oncology|February 21, 2023
High rate of postoperative upstaging of ductal carcinoma in situ when prioritizing ultrasound evaluation of mammography-detected lesions: a single-center retrospective cohort studyYung-Chun Hsieh, Chiao Lo, Yi-Hsuan Lee, et al.
Clinical Epidemiology|April 2, 2026
Cardiovascular Risks of Aromatase Inhibitors versus Tamoxifen in Postmenopausal Breast Cancer: A Multinational Cohort StudyShu-Chen Hu, Charles E Gaber, Chiao Lo, et al.
Annals of Surgical Oncology|July 21, 2016
Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without RadiotherapyShih-Fan Lai, Yu-Hsuan Chen, Wen-Hung Kuo, et al.
Breast Cancer Research : BCR|June 12, 2024
In situ HER2 RNA expression as a predictor of pathologic complete response of HER2-positive breast cancer patients receiving neoadjuvant chemotherapy and anti-HER2 targeted treatmentHuang-Chun Lien, Chiao Lo, Yi-Hsuang Lee, et al.
Breast Cancer Research : BCR|September 10, 2024
Characteristics and transcriptional regulators of spontaneous epithelial-mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinomaHuang-Chun Lien, Hui-Chieh Yu, Wen-Hsuan Yu, et al.
Frontiers in Oncology|December 6, 2021
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant TherapyPo-Han Lin, Ming-Yang Wang, Chiao Lo, et al.
Japanese Journal of Clinical Oncology|July 10, 2019
A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancerPo-Sheng Yang, Yi-Hsuan Lee, Chi-Feng Chung, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Biomed Research International|December 11, 2013
CYP19 genetic polymorphism haplotype AASA is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancerSung-Hsin Kuo, Shi-Yi Yang, Huang-Chun Lien, et al.
Surgical Oncology|October 21, 2021
Factors predicting one or two sentinel lymph nodes to be accepted for sentinel lymph node biopsy alone after neoadjuvant therapy in initially node-positive breast cancer patientsLi-Wei Tsai, Yi-Hsuan Lee, Chiao Lo, et al.
Cancer Science|January 21, 2020
Using next-generation sequencing to redefine BRCAness in triple-negative breast cancerPo-Han Lin, Ming Chen, Li-Wei Tsai, et al.
World Journal of Surgical Oncology|February 21, 2023
High rate of postoperative upstaging of ductal carcinoma in situ when prioritizing ultrasound evaluation of mammography-detected lesions: a single-center retrospective cohort studyYung-Chun Hsieh, Chiao Lo, Yi-Hsuan Lee, et al.
Clinical Epidemiology|April 2, 2026
Cardiovascular Risks of Aromatase Inhibitors versus Tamoxifen in Postmenopausal Breast Cancer: A Multinational Cohort StudyShu-Chen Hu, Charles E Gaber, Chiao Lo, et al.
Annals of Surgical Oncology|July 21, 2016
Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without RadiotherapyShih-Fan Lai, Yu-Hsuan Chen, Wen-Hung Kuo, et al.
Breast Cancer Research : BCR|June 12, 2024
In situ HER2 RNA expression as a predictor of pathologic complete response of HER2-positive breast cancer patients receiving neoadjuvant chemotherapy and anti-HER2 targeted treatmentHuang-Chun Lien, Chiao Lo, Yi-Hsuang Lee, et al.
Breast Cancer Research : BCR|September 10, 2024
Characteristics and transcriptional regulators of spontaneous epithelial-mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinomaHuang-Chun Lien, Hui-Chieh Yu, Wen-Hsuan Yu, et al.
Frontiers in Oncology|December 6, 2021
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant TherapyPo-Han Lin, Ming-Yang Wang, Chiao Lo, et al.
Japanese Journal of Clinical Oncology|July 10, 2019
A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancerPo-Sheng Yang, Yi-Hsuan Lee, Chi-Feng Chung, et al.
Pageof 5